No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia
12 Health Care Stocks Moving In Friday's Pre-Market Session
Sector Update: Health Care Stocks Rise in Afternoon Trading
Sector Update: Health Care
Why Is Silo Pharma Stock Gaining Today?
Silo Pharma Enters Collaboration Agreement With Kymanox For Specialized Design And Development Of A Subcutaneous Insertion Device For SP-26, The Company's Ketamine-Loaded Implant Therapeutic Targeting Fibromyalgia And Chronic Pain
No Data